Last reviewed · How we verify

NCT04836221: CARES

Comorbidities And Reducing inEquitieS

Completed NA Last updated 18 June 2023
What this trial tests

NA trial testing Support in Cancer, Breast in 63 participants. Completed in 10 June 2023.

Timeline
5 May 2021
Primary endpoint
10 June 2023
10 June 2023

Quick facts

Lead sponsorMedstar Health Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment63
Start date5 May 2021
Primary completion10 June 2023
Estimated completion10 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medstar Health Research Institute

Who can join

18 and older, any sex, with Cancer, Breast or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity. Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Identifying Complex Scheduling Patterns Among Patients With Cancer With Transportation and Housing Needs: Feasibility Pilot Study.
    Fong A, Boxley C, Schubel L, Gallagher C, et al · · 2025 · PMID 39828992 · DOI 10.2196/57715
  2. Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patients.
    Schubel LC, Barac A, Magee M, Mete M, et al · · 2025 · PMID 39810843 · DOI 10.1016/j.conctc.2024.101387

Verify or expand the search:

Other trials of Support

Trials testing the same drug.

Other recruiting trials for Cancer, Breast

Currently open trials in the same condition.

Other Medstar Health Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04836221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing